A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Effects of Zometa in Combination With Taxotere/Carboplatin in Patients With Stage IIIB/IV Unresectable Non-Small Cell Lung Cancer.

Trial Profile

A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Effects of Zometa in Combination With Taxotere/Carboplatin in Patients With Stage IIIB/IV Unresectable Non-Small Cell Lung Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Sep 2017

At a glance

  • Drugs Zoledronic acid (Primary) ; Carboplatin; Docetaxel
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Acronyms Z-PACT
  • Most Recent Events

    • 10 Nov 2009 Actual end date changed from Jul 2007 to Oct 2007 as reported by ClinicalTrials.gov.
    • 10 Nov 2009 Actual end date changed from Jul 2007 to Oct 2007 as reported by ClinicalTrials.gov.
    • 25 Jun 2008 Status changed from in progress to completed according to clinicaltrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top